17 min
The Role of Circulating Biomarkers in Heart Failure HFA Cardio Talk
-
- Medicine
With Henrike Arfsten,Medical University of Vienna - Austria & Antoni Bayes-Genis, Heart Institute, University Hospital Germans Trias and Pujol de Badalona - Spain
In this episode of HFA CardioTalk, Henrike Arfsten interviews Antoni Bayes-Genis on circulating biomarkers in heart failure. They focus in particular on natriuretic peptides and discuss the benefits of biomarkers assessment and their fundamental role in heart failure diagnosis and disease progression.
NEW! If you want to know more on this topic, access some recommended readings from the speakers:
- Bayes-Genis A, et al.; Eur J Heart Fail. 2023 Sep 15
- Mueller C, et al.; Eur J Heart Fail. 2019 Jun;21(6):715-731.
- Bayes-Genis A, et al.; Eur J Heart Fail. 2021:23,1432–1436.
- Huelsmann M, et al.; J Am Coll Cardiol. 2013 Oct 8;62(15):1365-72
- Tsutsui H, et al; Eur J Heart Fail. 2023 May;25(5):616-631.
With Henrike Arfsten,Medical University of Vienna - Austria & Antoni Bayes-Genis, Heart Institute, University Hospital Germans Trias and Pujol de Badalona - Spain
In this episode of HFA CardioTalk, Henrike Arfsten interviews Antoni Bayes-Genis on circulating biomarkers in heart failure. They focus in particular on natriuretic peptides and discuss the benefits of biomarkers assessment and their fundamental role in heart failure diagnosis and disease progression.
NEW! If you want to know more on this topic, access some recommended readings from the speakers:
- Bayes-Genis A, et al.; Eur J Heart Fail. 2023 Sep 15
- Mueller C, et al.; Eur J Heart Fail. 2019 Jun;21(6):715-731.
- Bayes-Genis A, et al.; Eur J Heart Fail. 2021:23,1432–1436.
- Huelsmann M, et al.; J Am Coll Cardiol. 2013 Oct 8;62(15):1365-72
- Tsutsui H, et al; Eur J Heart Fail. 2023 May;25(5):616-631.
17 min